These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 12164773)

  • 21. [Pharmacogenomics: the quest for individualized therapy].
    López-López M; Guerrero-Camacho JL; Familiar-López IM; Jung-Cook H; Corona-Vázquez T; Alonso-Vilatela ME
    Rev Neurol; 2004 Dec 1-15; 39(11):1063-71. PubMed ID: 15597270
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of drug transporter pharmacogenomics on pharmacokinetic and pharmacodynamic variability - considerations for drug development.
    Lai Y; Varma M; Feng B; Stephens JC; Kimoto E; El-Kattan A; Ichikawa K; Kikkawa H; Ono C; Suzuki A; Suzuki M; Yamamoto Y; Tremaine L
    Expert Opin Drug Metab Toxicol; 2012 Jun; 8(6):723-43. PubMed ID: 22509796
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ethnically diverse pluripotent stem cells for drug development.
    Fakunle ES; Loring JF
    Trends Mol Med; 2012 Dec; 18(12):709-16. PubMed ID: 23142148
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The promise of pharmacogenetics: assessing the prospects for disease and patient stratification.
    Smart A; Martin P
    Stud Hist Philos Biol Biomed Sci; 2006 Sep; 37(3):583-601. PubMed ID: 16980196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ethnicity and pharmacogenetics.
    Smith MW; Mendoza RP
    Mt Sinai J Med; 1996; 63(5-6):285-90. PubMed ID: 8898529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interethnic differences in genetic polymorphisms of CYP2D6 in the U.S. population: clinical implications.
    Bernard S; Neville KA; Nguyen AT; Flockhart DA
    Oncologist; 2006 Feb; 11(2):126-35. PubMed ID: 16476833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacogenetics in drug discovery and development: a translational perspective.
    Roses AD
    Nat Rev Drug Discov; 2008 Oct; 7(10):807-17. PubMed ID: 18806753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ontogeny and drug metabolism in newborns.
    Dotta A; Chukhlantseva N
    J Matern Fetal Neonatal Med; 2012 Oct; 25 Suppl 4():83-4. PubMed ID: 22958028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perspectives in pharmacogenetics.
    Kalow W
    Arch Pathol Lab Med; 2001 Jan; 125(1):77-80. PubMed ID: 11151057
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Application of toxicogenomics to drug development.
    Lakkis MM; DeCristofaro MF; Ahr HJ; Mansfield TA
    Expert Rev Mol Diagn; 2002 Jul; 2(4):337-45. PubMed ID: 12138498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Race, ethnicity, ancestry, and pharmacogenetics.
    Urban TJ
    Mt Sinai J Med; 2010; 77(2):133-9. PubMed ID: 20309922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epilepsy pharmacogenetics.
    Kasperaviciūte D; Sisodiya SM
    Pharmacogenomics; 2009 May; 10(5):817-36. PubMed ID: 19450130
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacogenetics and drug metabolism.
    Ball S; Borman N
    Nat Biotechnol; 1997 Oct; 15(10):925-6. PubMed ID: 9335033
    [No Abstract]   [Full Text] [Related]  

  • 34. HapMap, pharmacogenomics, and the goal of personalized prescribing.
    O'Shaughnessy KM
    Br J Clin Pharmacol; 2006 Jun; 61(6):783-6. PubMed ID: 16722846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Statistical concepts in the planning and evaluation of drug safety from clinical trials in drug development: issues of international harmonization.
    O'Neill RT
    Stat Med; 1995 May 15-30; 14(9-10):117-27. PubMed ID: 7569506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pharmacogenetics of oxidation reactions of drugs].
    Jacqz-Aigrain E
    Arch Fr Pediatr; 1989 Jan; 46(1):59-65. PubMed ID: 2653266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic polymorphism and toxicology--with emphasis on cytochrome p450.
    Johansson I; Ingelman-Sundberg M
    Toxicol Sci; 2011 Mar; 120(1):1-13. PubMed ID: 21149643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interethnic variability in human drug responses.
    Evans DA; McLeod HL; Pritchard S; Tariq M; Mobarek A
    Drug Metab Dispos; 2001 Apr; 29(4 Pt 2):606-10. PubMed ID: 11259361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of genomics on anti-infectives drug discovery and development.
    Parkinson T
    Trends Microbiol; 2002; 10(10 Suppl):S22-6. PubMed ID: 12377564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro ADME phenotyping in drug discovery: current challenges and future solutions.
    Williams JA; Bauman J; Cai H; Conlon K; Hansel S; Hurst S; Sadagopan N; Tugnait M; Zhang L; Sahi J
    Curr Opin Drug Discov Devel; 2005 Jan; 8(1):78-88. PubMed ID: 15679175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.